LONDON - AstraZeneca, which is fighting a $106 billion bid approach from Pfizer, said on Thursday it had launched a final-stage study of a key new lung cancer drug that ...
BY ANDREW M. SEAMAN NEW YORK - Despite concerns and some evidence that fertility treatments increase a woman's chances of developing breast cancer, a large, long term study finds no ...
BY BEN HIRSCHLER LONDON - GlaxoSmithKline Plc (GSK) has stopped a high-profile clinical trial using a novel vaccine to fight lung cancer after deciding it will not be possible to ...
Northwest Biotherapeutics Inc on Friday said an independent monitoring board had recommended that a late-stage study of its experimental brain-cancer treatment be continued, based on an interim safety review. The ...